Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018655 · ClinicalTrials.gov registry record · Phase 2
Integrated Intervention for Substance Abusers With Depressive Disorders
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 276
- Enrollment target
NCT00018655: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00018655 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 276 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (108% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00018655, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 276 participants
- Enrollment target
Study Summary
This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressive disorders versus the most commonly administered form of therapy for substance use disorders and depression, Twelve Step Facilitation (AA/NA model) group treatment plus medications.
Interventions
- BEHAVIORAL Twelve Step Facilitation
- BEHAVIORAL Integrated Cognitive Behavioral Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2000-04 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
What the finished NCT00018655 record still lists
NCT00018655 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (108% higher).
The record links to 0 conditions, and to 2 interventions - of which Twelve Step Facilitation is the first listed.
NCT00018655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00018655 about?
NCT00018655 is a clinical study titled "Integrated Intervention for Substance Abusers With Depressive Disorders". This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressive disorders versus the most commonly administered form of therapy for substance use disorders and depression, T...
What is the current status of trial NCT00018655?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 276 participants. The study started on 2000-04. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00018655?
The interventions under investigation include: Twelve Step Facilitation (BEHAVIORAL), Integrated Cognitive Behavioral Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00018655?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00018655's enrollment target sits among peer trials
276 202nd of 2000 higher than 1,798 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia